1. Home
  2. CASS vs RGNX Comparison

CASS vs RGNX Comparison

Compare CASS & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cass Information Systems Inc

CASS

Cass Information Systems Inc

N/A

Current Price

$55.47

Market Cap

714.9M

ML Signal

N/A

Logo REGENXBIO Inc.

RGNX

REGENXBIO Inc.

N/A

Current Price

$8.22

Market Cap

793.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CASS
RGNX
Founded
1906
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
714.9M
793.5M
IPO Year
1996
2015

Fundamental Metrics

Financial Performance
Metric
CASS
RGNX
Price
$55.47
$8.22
Analyst Decision
Buy
Strong Buy
Analyst Count
1
8
Target Price
$45.00
$28.75
AVG Volume (30 Days)
64.7K
1.2M
Earning Date
04-23-2026
05-05-2026
Dividend Yield
2.75%
N/A
EPS Growth
87.77
18.08
EPS
1.48
N/A
Revenue
$190,750,000.00
$10,393,000.00
Revenue This Year
$0.81
$51.21
Revenue Next Year
$4.39
$19.08
P/E Ratio
$37.38
N/A
Revenue Growth
N/A
126.48
52 Week Low
$36.07
$5.46
52 Week High
$59.63
$16.19

Technical Indicators

Market Signals
Indicator
CASS
RGNX
Relative Strength Index (RSI) 45.00 33.82
Support Level $51.22 $5.67
Resistance Level $59.63 $11.43
Average True Range (ATR) 1.14 0.47
MACD -0.19 -0.12
Stochastic Oscillator 24.76 5.04

Price Performance

Historical Comparison
CASS
RGNX

About CASS Cass Information Systems Inc

Cass Information Systems Inc is a provider of payment and information processing services to large manufacturing, distribution, and retail enterprises across the United States. The company provides transportation invoice rating, payment processing, auditing, accounting, and transportation information. It is also a processor and payer of energy invoices, including electricity, gas, waste, and other facility-related expenses. Additionally, the firm has a banking subsidiary, offering banking services mainly to privately held businesses in the St. Louis metropolitan area and restaurant franchises and faith-based ministries within the United States. The company operates in two reportable segments: Information Services, which generates the maximum revenue, and Banking Services.

About RGNX REGENXBIO Inc.

Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.

Share on Social Networks: